2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Monday, December 14, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Imaging, Pathology, Serologic Tests, Bioinformatics, Cell Expansion, Computational Biology, Emerging Technologies, Profiling, Treatment Considerations, Drug Development, Therapy Sequence, Biological Therapies, Antibody Therapy, Transplantation, Immunotherapy, Monoclonal Antibody Therapy, Non-Biological Therapies, Chemotherapy, Adverse Events, Biological Processes, Apoptosis, Pathogenesis, Hematopoiesis, Immune Mechanism, Microbiome, Molecular Biology, Diseases, Immunology, GVHD, Neutropenia, Infectious Diseases, Bacterial, Lymphoid Malignancies, Lymphoid Leukemias, Plasma Cell Disorders, Myeloid Malignancies, Acute Myeloid Malignancies, Research, Fundamental Science, AML, Translational Research, Study Population, Human, Adult, Animal Model
PAPER

5850 Clinical antibiotic exposure and ddpcr modeling identify secondary bile acids as candidate modulators of enterococcus growth after allo-HCT

Jennifer Angelica Funes, MS, Zeyang Li, PhD2, Nathan Duong, BS3, Itaua Leston Araujo Sr, Postdoctoral Research4, Liquing Wang, PhD5, Yuqing Chen, MS6, Keimya Sadeghi, MS7, Natalie Grier Smith, BA8, Amina Lazrak, MS9, Arnab Chowdhury, MS10, Yi-Tzu Lin, PhD11, Ryotaro Nakamura, MD12, Joycelynne Palmer, PhD13, Antonio Luiz LC Cruz Gomes, PhD14, Robert Jenq, MD, PhD15, Tyler Funnell, PhD16, Jenny Paredes, PhD17, Marcel R.M. van den Brink Jr, M.D., Ph.D.18
1 City of Hope, Duarte, California, United States
2 City of Hope, Duarte, California, United States
3 City of Hope, Duarte, California, United States
4 City of Hope, Duarte, California, United States
5 City of Hope, Duarte, California, United States
6 City of Hope, Duarte, California, United States
7 City of Hope, Duarte, California, United States
8 City of Hope, Duarte, California, United States
9 City of Hope, Duarte, California, United States
10 City of Hope, Duarte, California, United States
11 City of Hope, Duarte, California, United States
12 City of Hope, Duarte, California, United States
13 City of Hope, Duarte, California, United States
14 City of Hope, Duarte, California, United States
15 City of Hope, Duarte, California, United States
16 City of Hope, Duarte, California, United States
17 City of Hope, Duarte, California, United States
18 City of Hope, Duarte, California, United States

Background

Enterococcus domination is a clinically important dysbiosis after allogeneic hematopoietic cell transplantation (allo-HCT), associated with GVHD, bloodstream infection, and mortality. We previously demonstrated that meropenem and metronidazole exposure in allo-HCT patients is associated with shifts toward Enterococcus-high, low-diversity microbiome states (Nguyen et al., Cell, 2023). We also previously demonstrated that GVHD is linked to altered microbial bile acid (BA) metabolism, including reduced bile salt hydrolase (bsh) gene abundance, depletion of microbe-derived immunoregulatory BAs such as isolithocholic acid (isoLCA), and improved clinical outcomes associated with ursodeoxycholic acid (UDCA) exposure (Lindner et al., Nature Microbiology, 2024). We hypothesized that clinically relevant antibiotic-induced Enterococcus bloom can be modeled experimentally and used to identify BA metabolites with direct activity against E. faecalis, a species of clinical interest in allo-HCT.

Methods

We evaluated early post-transplant anti-anaerobic antibiotic exposure (days 0-30) in 3,913 adult allo-HCT recipients at City of Hope (from 2012 to 2025) and tested associations with overall survival (OS) using multivariable Cox models. To model antibiotic-induced bloom, allo-HCT mice (C57BL/6J to BALB/cJ) received meropenem (0.625 g/L) or metronidazole (0.25, 0.5, or 1.0 g/L) in drinking water from days +3 to +15. Fecal samples collected on days +3, +6, +9, +13, +15, and +17 were analyzed using droplet digital PCR (ddPCR), which quantifies absolute copy numbers of primer-defined bacterial DNA targets. Thus, Enterococcus-specific ddPCR provides a direct molecular readout of bacterial burden, while E. faecalis-specific bsh ddPCR quantifies copies of a gene encoding bsh capacity. We screened secondary BAs against E. faecalis by exposing cultures to isoLCA, isoallolithocholic acid (isoalloLCA), lithocholic acid (LCA), allolithocholic acid (alloLCA), or UDCA at 10, 50, or 100 µM for 24 hours. Growth inhibition was assessed by ddPCR and compared with OD600 and colony-forming units.

Results

In the clinical cohort, meropenem and metronidazole represented 89% of anti-anaerobic antibiotic exposures and were administered to 548 and 530 allo-HCT recipients, respectively. Early meropenem exposure was associated with inferior OS (adjusted P<0.0001), consistent with prior reports; metronidazole exposure was also associated with inferior OS (adjusted P=0.029).

Next, we tested the effect of these antibiotics on absolute Enterococcus concentration in a controlled setting. In murine allo-HCT, ddPCR detected meropenem-induced Enterococcus bloom beginning on day +6 (adjusted P=0.048). Metronidazole induced dose-dependent Enterococcus expansion, peaking on day +12, with all doses increased over controls (adjusted P=0.034) and persistent bloom through day +15 at 0.5 and 1.0 g/L (adjusted P=0.034).  Enterococcus and E.faecalis-specific bsh gene copy numbers were highly correlated in the meropenem and metronidazole experiments (both Spearman ρ = 0.87, P < 2.2 × 10⁻¹⁶), indicating that these expansions of endogenous Enterococcus were primarily composed of E. faecalis.

We then screened BAs for their effects on E. faecalis in vitro. isoLCA, a microbe-derived BA previously implicated in T-cell immunoregulation and depleted during GVHD, produced significant dose-dependent reductions in E. faecalis growth by ddPCR (adjusted P<0.04), concordant with OD600 and CFU. IsoalloLCA also inhibited growth at higher concentrations.

Conclusions

We developed a rapid ddPCR platform for absolute, targeted quantification of antibiotic-induced Enterococcus bloom, addressing a key limitation of relative-abundance sequencing for translational screening. By integrating clinical antibiotic exposure and allo-HCT mouse modeling, this work suggests that shorter survival after allo-HCT may be caused in part by increased concentrations of intestinal Enterococcus, rather than merely loss of competing bacteria. The inhibition of E. faecalis by isoLCA, together with prior evidence that GVHD is associated with depletion of microbe-derived immunoregulatory BAs, suggests that specific BA pool components may modulate pathobiont expansion. This platform can rapidly test how individual BA metabolites and broader BA pool changes influence Enterococcus growth in GVHD-risk states.

Jennifer Angelica Funes, MS: No relevant conflicts of interest to declare.